Prevalence of combined and noncombined dyslipidemia in an Iranian population

Combination of dyslipidemic phenotypes, including elevated plasma levels of low‐density lipoprotein cholesterol (LDL‐C), elevated plasma triglycerides (TG), and decreased low‐density lipoprotein cholesterol (HDL‐C) concentrations, is important because of the association of individual phenotypes with increased risk of cardiovascular disease (CVD). We investigated the prevalence of combined dyslipidemias and their effects on CVD risk in an Iranian large population.

[1]  P. Valensi,et al.  Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study , 2016, Cardiovascular Diabetology.

[2]  D. Simons-Morton,et al.  Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report , 2016, Pediatric Clinical Practice Guidelines & Policies.

[3]  B. Bijari,et al.  Prevalence of Dyslipidemia among Elementary School Children in Birjand, East of Iran, 2012 , 2016, The journal of Tehran Heart Center.

[4]  Abolfazl Mohammadbeigi,et al.  Dyslipidemia Prevalence in Iranian Adult Men: The Impact of Population-Based Screening on the Detection of Undiagnosed Patients , 2015, The world journal of men's health.

[5]  B. Bijari,et al.  Lipid Profiles and Prevalence of Dyslipidemia in Eastern Iranian Adolescents, Birjand, 2012 , 2015, Iranian journal of medical sciences.

[6]  M. Azarpazhooh,et al.  Mashhad stroke and heart atherosclerotic disorder (MASHAD) study: design, baseline characteristics and 10-year cardiovascular risk estimation , 2015, International Journal of Public Health.

[7]  A. Avan,et al.  The lipoprotein lipase S447X and cholesteryl ester transfer protein rs5882 polymorphisms and their relationship with lipid profile in human serum of obese individuals. , 2015, Gene.

[8]  A. Avan,et al.  Metabolic syndrome components as markers to prognosticate the risk of developing chronic kidney disease: evidence-based study with 6492 individuals , 2015, Journal of Epidemiology & Community Health.

[9]  E. Gaudio,et al.  Nonalcoholic fatty liver disease and the heart in children and adolescents. , 2014, World journal of gastroenterology.

[10]  M. Qorbani,et al.  Prevalence of Dyslipidemia in Iran: A Systematic Review and Meta-Analysis Study , 2014, International journal of preventive medicine.

[11]  M. Banach,et al.  Combined dyslipidemia: should the focus be LDL cholesterol or atherogenic dyslipidemia? , 2013, Current pharmaceutical design.

[12]  Gary S Collins,et al.  Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2 , 2012, BMJ : British Medical Journal.

[13]  R. Pratesi,et al.  Atherosclerosis in young Brazilians suffering violent deaths: a pathological study , 2011, BMC Research Notes.

[14]  T. Jones,et al.  High incidence of obesity co‐morbidities in young children: A cross‐sectional study , 2011, Journal of paediatrics and child health.

[15]  D. Simons-Morton,et al.  Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report , 2011, Pediatrics.

[16]  Moshe Levi,et al.  Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. , 2011, Circulation.

[17]  P. Yoon,et al.  Prevalence of abnormal lipid levels among youths --- United States, 1999-2006. , 2010, MMWR. Morbidity and mortality weekly report.

[18]  Atlanta,et al.  Prevalence of abnormal lipid levels among youths --- United States, 1999-2006. , 2010, MMWR. Morbidity and mortality weekly report.

[19]  F. Aslam,et al.  Peripheral Arterial Disease: Current Perspectives and New Trends in Management , 2009, Southern medical journal.

[20]  H. Cohen,et al.  Association of Lipid Abnormalities With Measures and Severity of Adiposity and Insulin Resistance Among Overweight Children and Adolescents , 2009, Journal of clinical hypertension.

[21]  A. Mooradian.  Dyslipidemia in type 2 diabetes mellitus , 2009, Nature Clinical Practice Endocrinology &Metabolism.

[22]  Sidney C. Smith.  Multiple risk factors for cardiovascular disease and diabetes mellitus. , 2007, The American journal of medicine.

[23]  A. Mokdad,et al.  Trends in Risk Factors for Cardiovascular Disease Among Children and Adolescents in the United States , 2004, Pediatrics.

[24]  S. Daniels,et al.  Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, , 2003, Circulation.

[25]  M. Rafiei,et al.  Risk factors for coronary artery disease in Isfahan, Iran , 1999 .

[26]  J. Gamble,et al.  High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[27]  R. L. Russell,et al.  A possible role of calcium in the action of glucagon, cAMP and dibutyryl cAMP on the metabolism of free fatty acids by rat hepatocytes. , 1978, Biochemical and biophysical research communications.